William Blair Investment Management LLC Lowers Stock Position in Maximus, Inc. $MMS

William Blair Investment Management LLC decreased its holdings in Maximus, Inc. (NYSE:MMS) by 25.1% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 345,310 shares of the health services provider’s stock after selling 115,925 shares during the quarter. William Blair Investment Management LLC’s holdings in Maximus were worth $31,551,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Choreo LLC increased its holdings in shares of Maximus by 100.7% in the 3rd quarter. Choreo LLC now owns 7,045 shares of the health services provider’s stock valued at $644,000 after acquiring an additional 3,534 shares during the period. US Bancorp DE grew its stake in Maximus by 5.5% in the third quarter. US Bancorp DE now owns 4,782 shares of the health services provider’s stock valued at $437,000 after purchasing an additional 248 shares during the last quarter. Fox Run Management L.L.C. raised its holdings in Maximus by 70.3% in the third quarter. Fox Run Management L.L.C. now owns 16,491 shares of the health services provider’s stock worth $1,507,000 after purchasing an additional 6,806 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Maximus by 14.6% during the third quarter. EverSource Wealth Advisors LLC now owns 2,032 shares of the health services provider’s stock valued at $186,000 after buying an additional 259 shares during the last quarter. Finally, GSA Capital Partners LLP bought a new stake in shares of Maximus in the 3rd quarter valued at about $240,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Price Performance

NYSE MMS opened at $75.52 on Monday. The stock’s fifty day moving average price is $86.80 and its 200 day moving average price is $86.39. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $100.00. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. The company has a market cap of $4.12 billion, a price-to-earnings ratio of 11.49 and a beta of 0.59.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the previous year, the business earned $1.61 EPS. The company’s quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be issued a $0.33 dividend. This is an increase from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 annualized dividend and a dividend yield of 1.7%. Maximus’s payout ratio is currently 20.09%.

Insider Transactions at Maximus

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the company’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total value of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This represents a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bruce Caswell acquired 3,175 shares of Maximus stock in a transaction on Tuesday, February 10th. The shares were bought at an average price of $78.45 per share, with a total value of $249,078.75. Following the purchase, the chief executive officer directly owned 328,013 shares in the company, valued at approximately $25,732,619.85. The trade was a 0.98% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Weiss Ratings downgraded shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Finally, Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Maximus has an average rating of “Buy”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.